SCHEMBL801740

SCHEMBL801740

CC(C)(C)c1ccc2cc(P(=O)(c3ccccc3)c3ccc4c(c3)c3ccccc3n4-c3ccccc3)ccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.41
▸ ATM Q13315 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PPARG P37231 4/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ PPARA Q07869 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ PGR P06401 1/20 0.35
▸ RORA P35398 1/20 0.35
▸ RORC P51449 1/20 0.35
▸ RORB Q92753 1/20 0.35
▸ DNMT1 P26358 3/20 0.33
▸ MAT2A P31153 1/20 0.33
▸ ECE1 P42892 1/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL801486 0.98 PPARG (0.40) KDM4EATML3MBTL1PPARGNPSR1
SCHEMBL801165 0.94 PPARG (0.38) KDM4EPPARGNPSR1PPARAMAPT
SCHEMBL801133 0.88 KDM4E (0.47) KDM4EATML3MBTL1NPSR1MAPT
SCHEMBL801604 0.88 PPARG (0.38) KDM4EATML3MBTL1PPARGNPSR1
SCHEMBL801721 0.87 PPARG (0.42) KDM4EATML3MBTL1PPARGNPSR1
SCHEMBL801164 0.85 PPARG (0.41) KDM4EPPARGNPSR1PPARAMAPT
SCHEMBL801302 0.85 KDM4E (0.50) KDM4EATML3MBTL1NPSR1ALDH1A1
SCHEMBL801297 0.85 KDM4E (0.56) KDM4EATML3MBTL1NPSR1MAPT
SCHEMBL801298 0.85 KDM4E (0.56) KDM4EATML3MBTL1NPSR1MAPT
SCHEMBL30281357 0.85 KDM4E (0.56) KDM4EATML3MBTL1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-9278986-B2 Carbazole-based phosphine oxide compound, and organic electroluminescent device including the same SK CHEMICALS CO., LTD. (KR) 2016-03-08 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INDUSTRY-ACADEMIC COOPERATION FOUNDATION, DANKOOK UNIVERSITY (KR) 2012-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120068168-A1 CARBAZOLE-BASED PHOSPHINE OXIDE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME INPP5B, EZH2, PLCB3 KDM4E 1186/4885ATM 3758/4885L3MBTL1 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback